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In the treatment of esophageal cancer and palliative care, nutritional status plays 
an important role in the patients’ tolerance of treatment, affects the quality of life, 
and outcomes. Alimentation in such patients can be achieved by enteral or paren-
teral nutrition but the enteral route is the preferring option. Pre-pyloric feeding 
is easier and may result in greater nutritional benefits than post-pyloric feeding. 
Gastrostomy is the conventional option for intra-gastric feeding, hydration, and 
drug administration. Percutaneous endoscopic gastrostomy (PEG) is a minimally 
invasive procedure and is currently the procedure of choice. Two PEG techniques 
are clinically used worldwide: pull and push or introducer method. The pull-type 
technique is the most commonly used method, but the concerning point is that the 
implantation of esophageal cancer cells into the gastrostomy stroma. The intro-
ducer method is a safe alternative and effective technique for enteral feeding to the 
stomach with the avoidance of cancer cells seeding.
Keywords: enteral nutrition, palliative care, percutaneous endoscopic gastrostomy, 
introducer PEG, esophageal cancer, dysphagia, cancer cells seeding
1. Introduction
In 2018, global cancer statistics reported that the incidence of esophageal cancer 
and mortality were 572,000 new cases and 509,000 deaths, ranking seventh and 
sixth of all cause cancer morbidity and mortality, Thus, esophageal cancer is a 
significant global health problem [1]. Most cases present late with advanced disease, 
especially in the developing countries [1]. Local tumor growth leads to esophageal 
lumen narrowing and dysphagia and results in increasing difficulty with eating 
solid food, weight loss and worsening nutritional status. Improving nutritional 
status is a key factor in determining patient’s ability to perform activities of daily 
living, tolerability of multimodal anticancer treatment, long-term outcomes, and 
quality of life [2–6].
Percutaneous endoscopic gastrostomy (PEG) is a safe and effective minimally 
invasive option [7, 8]. Two primary PEG techniques are used worldwide: the pull 
and push/introducer methods [9, 10]. The pull technique was introduced first and 
more widely used but cancer seeding through the gastrostomy stroma is a rare but 
Palliative Care
2
concern disadvantage [11–15]. Refining the pull technique led to the development of 
the push or introducer technique to avoid tumor seeding to the stroma [9, 16–18].
2.  History and concept of the development of the introducer 
percutaneous endoscopic gastrostomy
Alimentation for esophageal cancer patients can be provided via the enteral or par-
enteral routes [2, 19, 20]; the enteral route is preferred because it utilizes the gastro-
intestinal tract and avoids the complications of parenteral nutrition [21, 22]. Placing 
the feeding tube distally to the location of the cancer is the strategy. Enteral nutrition 
can be provided by pre-pyloric or post-pyloric feeding (Table 1). Intragastric feeding 
is easier and might provide greater physiologic benefits than the small bowel [23, 24]. 
The technical approaches of pre-pyloric nutrition include a nasogastric tube (NGT), 
surgical gastrostomy, and PEG.
NGT is a classic approach for the patient with swallowing difficulties [25]. 
For early esophageal cancer, when patients may have mild dysphagia and limited 
luminal obstruction, a NGT should be able to pass easily. However, with advanced 
disease, the passing of a NGT requires endoscopic or fluoroscopic guidance to 
confirm the correct position of NGT before start the feeding process [8].
A surgical gastrostomy may be performed by an open approach whereby the 
feeding tube is placed in the stomach via an upper midline incision. This approach 
is associated with potential complications such as wound infection [26–29] and 
respiratory compromise [27, 30–33]. The laparoscopic gastrostomy was developed 
to minimize the risks of the open technique but it requires substantial training, a 
skillful surgeon, and experience [34, 35].
PEG was first performed in 1979, using the pull-type technique [36]. This 
approach was associated with fewer procedural complications than surgical gas-
trostomy [37–40]. The pull method involves inserting a string into the intragastric 
space through the abdominal wall. The forceps from an endoscopy grasps the string 
and pulls it up to the oral cavity. A feeding tube is then passed over the guide string 
and pushed back down the esophagus, stomach, and then out through the abdomi-
nal wall. The pull-type technique is the most commonly used method in clinical 




Risk of cancer 
seeding
Nasogastric tube (NGT) + — —
Nasojejunal tube (NJT) — + —
Surgical approach
Gastrostomy + — —
Jejunostomy — + —
Percutaneous endoscopic gastrostomy (PEG)
Pull technique + — +
Push or Introducer technique + — —
Percutaneous endoscopic transgastric jejunostomy 
(PEG-J)
— + —
+ yes; − no.
Table 1. 
Methods for enteral nutrition in esophageal cancer patients.
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practice. However, a rare complication is the implantation of esophageal cancer cells 
into the gastrostomy stroma [11, 12].
The push or introducer method is an alternative PEG technique that avoids seed-
ing cancer cells seeding by direct inoculation during the procedure [13–15, 17, 18].  
The push technique involves inserting a guidewire into the stomach through the 
abdominal wall and then passing the feeding tube over the wire to rest in the 
stomach [41, 42]. In the Russell technique, once the guidewire is in the intragastric 
space, a dilator with a sheath is passed over the wire. After removing the dilator and 
guidewire, the feeding tube is inserted into the sheath, and the sheath is then peeled 
off [43]. The push method is associated with fewer complications than the pull 
method [10, 16, 41, 42].
Both PEG methods are also associated with better short-term outcomes over 
surgical gastrostomy in terms of shorter operative duration, less post-operative 
pain, and shorter hospitalization [17, 18].
3. Introducer percutaneous endoscopic gastrostomy in palliative care
In palliative care, advanced esophageal cancer patients have suffered from many 
symptoms such as pain, dysphagia, malnutrition, and psychological problems that 
depend on the tumor location with staging and the cancer current treatments [44]. 
Nutritional support is one of the critical roles for symptom management, especially 
for dysphagia and malnutrition. Also, nausea and vomiting might be the other 
symptom caused by chemotherapy, radiation, medication, and psychiatric issues 
that affected the patients’ nutritional status [44, 45].
Enteral nutrition is a suitable option for managing these conditions for improv-
ing nutritional status, increasing tolerating for chemoradiation therapy, and 
enhancing the patients’ quality of life. The preference for enteral nutrition of 
advanced esophageal cancer should be safe, minimally invasive with the ability to 
help in nutritional status. The introducer PEG is a practical choice for advanced 
esophageal cancer patients who had been included in palliative care [46–48].
4. Indications and contraindications
Clinical assessment to create accurate clinical staging is a crucial step for guiding 
the optimal management of esophageal cancer patients. Endoscopic resection is an 
option for the treatment of early esophageal cancer. Tri-modality therapy is an alterna-
tive for patients who have more advanced local disease and for patients with metastases 
group, palliative and supportive care are indicated to improve quality of life [49–51].
Esophageal cancer is often cause anorexia and dysphagia that lead to decreased 
oral intake and poor nutritional status, dehydration, imbalance of blood chemistry, 
and malnutrition. Assessing patient’s performance status is a crucial for drawing up 
the treatment plan, irrespective of stage of the disease. Nutrition support is a key 
element and is indicated in patients whose nutritional status is compromised who 
cannot be adequately supported by eating and drinking normally. Enteral feeding is 
the route of first choice and preserves intestinal integrity, has a low risk of compli-
cations, and is more cost effective than the parenteral route [2, 52, 53].
NGT is a common practice for enteral nutrition. Passing a nasojejunal tube 
(NJT) is another enteral nutrition technique but this is technically more challenging 
[54]. Both NGT and NJT are intended for short-term nutritional support, usually up 




Although surgery plays a long history of enteral nutrition, the various pro-
cedures have developed to reduce complications, pain, and additional cosmetic 
results. Pull-type or introducer PEG is a favored method for a minimally invasive 
procedure, avoiding the risk of cancer seeding compared to surgical gastrostomy 
[17, 18]. In addition to patients with esophageal cancer, the introducer PEG could 
also use in patients who indicated enteral nutrition support with pre-pyloric feed-
ing, demand for long-term enteral feeding, the patients with head and neck cancer 
that could diminish the risk of cancer seeding from PEG procedure, and apply for 
gastric decompression [9, 25, 55, 56].
The contraindications for a PEG include: patients with unstable vital signs, 
sepsis, uncorrected coagulopathy, gastric outlet obstruction or intestinal obstruction 
as well as patients who have endoscopic contraindications such as a viscus perfora-
tion, gastric pathology or severe abdominal wall infection especially at the site for 
the feeding tube, massive ascites, pregnancy, caustic esophageal or gastric injuries, 
and previous gastric or intra-abdominal surgery (Table 2) [9, 57].
5.  Principle of techniques for introducer percutaneous endoscopic 
gastrostomy
The introducer PEG is performed with the patient in the supine position under 
local anesthesia, intravenous sedation, or general anesthesia. EGD is necessary for 
visualization of the stomach during the procedure. For the patients with advanced 
local disease and dysphagia, the standard diameter endoscope (8–12 mm) [58] 
might not pass through the narrowed esophageal lumen, necessitating the use of the 
pediatric endoscope, which has a smaller diameter (4.9–6 mm) [59].
Gastropexy is a technique that anchors the stomach wall to the abdominal wall 
before the feeding tube is inserted; one method is the double needle gastropexy 
(Figure 1). The double-needle gastropexy is a device with two parallel, 20-gauge 
needles, and a suture-holding loop. The suture-holding loop inserts through the 
first needle and the suture inserts through the second needle which is grasped with 
Indications
For esophageal cancer
Enteral nutrition support with pre-pyloric feeding
Minimize the risk of cancer seeding from PEG procedure










Severe abdominal wall infection (especially at the site for the feeding tube)
Massive ascites
Pregnancy
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the snare. The needles are withdrawn, and the suture is tied to the left upper quad-
rant of the anterior abdominal wall. A second gastropexy is performed 2–3 cm apart 
in the same way. The gastric wall is then punctured and the dilator inserted over the 
guidewire, followed by the gastrostomy tube (Figure 1) [16, 17].
Previous abdominal surgery of the upper abdomen is a relative contraindication 
because of altered intra-abdominal anatomy [9, 60]. However, there are reports 
that safe PEG introduction can be achieved safely with the use of transillumination 
(using an endoscope passed through the abdominal wall with clear endoscopic 
intra-gastric visualization by external palpation) [61], a plain abdominal film with 
air insufflation technique, and computed tomography guided PEG [62–64], and 
laparoscopic-assisted PEG. These techniques aim to avoid intra-abdominal organ 
injury [18, 65].
Although the introducer PEG is a proven effective and safe procedure, it suffers 
the limitation of requiring endoscopy. Passing the endoscope beyond the tumor 
may be difficult and there is a risk of esophageal perforation in severe esophageal 
luminal occlusion. In advanced cases, surgical gastrostomy and laparoscopic-
assisted PEG are the alternative procedures [17, 18]. A recent study published the 
comparison of both techniques, and the laparoscopic-assisted PEG had advantages 
in the procedural duration, blood loss, postoperative pain, and hospitalization [18].
6. Complications
Although the push/introducer PEG is a minimally invasive technique that 
demonstrates a method in enteral nutrition [10, 17, 18, 66, 67], it is associated 
with several complications [9, 17, 68], including death in patients with underlying 
comorbidities [69].
Bleeding is the most common complication and is usually minor and manifest 
as oozing around the feeding tube. Apply the simple compression should stop the 
bleeding. If the bleeding more severe, it might be due to injury to e.g. gastric and 
Figure 1. 
Percutaneous Endoscopic Gastrostomy (PEG); Endoscopic view of introducer technique. (A) Double-needle 
gastropexy. (B) Puncture of the double-needle gastropexy and forming the loop to hold the suture. (C) The suture 
from one of the needles passes through the loop wire from the other needle and tightens the loop. The double-
needle device is removed. (D) Puncture and insertion the dilating catheter over the guidewire. (E) The dilating 
catheter and guidewire are removed. (F) The gastrostomy tube is inserted through the sheath, and then the sheath 
is peeled away. (G) The bumper of a 24 Fr bumper-type gastrostomy tube (IDEAL PEG Kit; MD-43430; Akita 
Sumitomo Bakelite Co. Ltd., Akita, Japan).
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gastroepiploic arteries. A pressure dressing is often effective but if bleeding contin-
ues, it can be treated by endoscopy, embolization, or surgery [9, 17, 57]. Selecting 
carefully the correct anatomical site and correcting a coagulopathy, if present, 
should prevent or minimize the risk of bleeding complications.
Abdominal organ injuries to the small bowel, colon, liver, and spleen may 
occur caused by the interposition of these organs between the gastric wall and the 
abdominal wall [9, 57, 70–73]. EGD should always be performed using transillumi-
nation, for clear intra-gastric visualization, and external palpation to identify and 
interposition of the internal organs [61]. If there is doubt, then laparoscopy can be 
performed to assure direct visualization of the intra-abdominal cavity [18].
Aspiration pneumonia is a severe complication and is associated with a mortality 
of PEG [9, 57]. Esophageal cancer patients, especially in elderly, heavy smokers with 
or without chronic obstructive pulmonary disease (COPD), have a higher risk of 
aspiration pneumonia compared to other patients and is related to residual liquid or 
food in the esophagus proximal to the obstruction. By technical for advanced esopha-
geal cancer patients, the pediatric endoscope often chosen for the PEG procedure. 
The endoscope’s small diameter is followed by the small endoscopic channel, result-
ing in less suction performance than the standard endoscope. Measures to reduce 
the risk of aspiration include the use of topical pharyngeal anesthesia rather than 
sedation, frequent mouth suction, and the reverse Trendelenburg position [74, 75].
The buried bumper syndrome (BBS) occurs when the internal bumper erodes into 
the wall of the stomach and sometimes becomes entirely buried within the gastric 
wall. It might cause by a disproportionate size and length of the feeding tube with the 
thickness of the abdominal wall. The main causative factor is excessive tightening of 
the external bumper, leading to increased pressure of the internal bumper on the wall 
of the stomach, local ischemia and gastric wall erosion (Figure 2). Additional risk 
factors include obesity, weight gain, malnutrition, corticosteroid therapy, and poor 
wound healing. BBS is a late complication and usually occurs > one year post PEG 
but it may be seen within several weeks of PEG placement. It may be asymptomatic 
or cause pain. Malfunction of the PEG is common, leading to leakage around the 
entry site, difficulty administering the feeds, fluids or drugs, infection, abscess or 
peritonitis [76, 77]. If BBS occurs, the tube should be removed by endoscopy, surgical 
intervention, or external traction, depending on the type of feeding tube and the 
patient’s situation [9, 77, 78].
Necrotizing fasciitis is the rare and severe PEG complication and is associated 
with a high mortality. Local ischemia leads to bacterial infection with a mix of 
anaerobic and aerobic organisms from gastrointestinal tract and skin. The infection 
progresses rapidly along with fascial plane and causes extensive abdominal fascia 
necrosis [79]. Treatment includes urgent aggressive and wide surgical debridement, 
intravenous broad-spectrum antibiotics and close clinical monitoring in the inten-
sive care unit [9, 80–82]. The prognosis is very poor.
Granuloma formation is a minor but common complication that results from 
peristomal hyper-granulation due to friction of the PEG tube and humidity due 
to tube leakage [83, 84]. Patients are prone to local infection and contact bleeding. 
Treatment includes topical antibiotics, topical steroids, electrocauterization, or 
cauterizing by silver nitrate. Surgical debridement may be required for sizeable 
peristomal granulomas [9, 83, 85].
Peristomal leakage and local infection are also minor complications that causing 
discomfort, pain and annoyance for patients and their families. Good peristomal 
hygiene and dressings combined with reducing the volume of feeds and minimizing 
PEG tube movements are treatment options. If these failed, removing the PEG tube 
and placing it in another area can be done or abandoning PEG enteral feeding for 
another form. [9, 57, 68].
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7. Conclusion
Percutaneous endoscopic gastrostomy is a minimally invasive procedure for 
the patients who need enteral nutrition support, hydration, and medications. 
For esophageal cancer patients and palliative care, the introducer technique is the 
optimal technique and prevents cancer seeding from the operative procedure.
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pressure and ischemic necrosis, the internal migrates through the gastric wall into the abdominal wall (B).  
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